Editorial Comment to Therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate and high-risk prostate cancer

Int J Urol. 2015 May;22(5):482-3. doi: 10.1111/iju.12713. Epub 2015 Feb 17.

Author

Yasuo Yoshioka¹

Affiliation

¹ Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan. [email protected].

PMID: 25691213
DOI: 10.1111/iju.12713

No abstract available

Publication types

Editorial
Comment

MeSH terms

Androgen Antagonists / therapeutic use*
Humans
Male
Neoadjuvant Therapy*
Prostatic Neoplasms / mortality*
Prostatic Neoplasms / therapy*
Radiotherapy, Intensity-Modulated*

Substances

Androgen Antagonists